Abstract

Microcin 24 is an antimicrobial peptide produced by Escherichia coli with activity against Salmonella typhimurium. In this study, microcin 24 was investigated for its potential use in food safety, resistance development, and structure-activity relationship following sitedirected mutagenesis. An attempt was made to produce microcin 24 from lactic acid bacteria by substituting the natural, dedicated leader peptide in the microcin-producing gene with a signal leader from divergicin A which accesses the general secretion pathway. RNA sequences could be recovered from Carnobacterium divergens harboring an expression vector with the fusion construct, but no microcin activity could be detected. Concurrently, development of and mechanism of resistance to microcin 24 was investigated by repeatedly exposing susceptible S. typhimurium to the microcin. The exposed S. typhimurium harbored an inducible regulator, marR, of the multiple antibiotic resistance (mar) regulon. These experiments showed that S. typhimurium could become resistant to microcin 24 through activation of the mar system leading to concurrent resistance to ciprofloxacin, chloramphenicol, rifampin, and tetracycline. Subsequently, an experiment was performed to demonstrate if microcin 24-producing E. coli could reduce S. typhimurium shedding in pigs and to demonstrate that this exposure could lead to microcin 24 resistance and mar activation in vivo. The results did not provide evidence of an effect on Salmonella shedding or mar activation under the conditions of the experiment. Site-directed mutagenesis performed in a conserved region of microcin 24 indicated that lysine substitutions introduced into a proposed hydrophobic face of a predicted amphipathic a-helix eliminated or severely reduced microcin activity. Other mutations in the microcin 24 gene were shown to affect microcin activity as well. Additional experiments provided evidence that microcin 24 is a bifunctional molecule with membrane and endonuclease activity.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.